A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
News Que Dallara on Medtronic’s diabetes spinoff, pipeline and Abbott partnershipHealthradar26. September 2025 Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Que Dallara,…
Gadgets WELL Health Subsidiary WELLSTAR Provides Corporate Update Reflecting Improved Guidance and a Strong Acquisition PipelineHealthradar18. Juli 2025 WELLSTAR continues to demonstrate strong growth and business momentum through its sustained organic growth and strong acquisition pipeline. The business…
